Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VAXGEN INC. (VXGN)- The IPO -- Ignore unavailable to you. Want to Upgrade?

To: GPSite who wrote (31)	7/11/1999 2:31:00 PM
From: gary r. albrecht	Read Replies (1) \| Respond to of 55

Once again GPSite thanks for taking the time to explain. I am familiar with empirical work (economics) which leads me to wonder -- in phases I and II 2000 humans were vaccinated with AIDSVAX, admittedly little was known about dosages, but surely these 2000 have been followed, do we know ANYTHING about whether any of these 2000 have subsequently been infected with HIV? gary

To: GPSite who wrote (31)	7/12/1999 2:00:00 AM
From: Manfred Sondermann	Read Replies (2) \| Respond to of 55

>VaxGen will have the technology, the mechanics of production, the >patents, and the backing of Genentech. As far as I read in the prospectus, Genentech is the owner of the patents. So if everyone will work someday one a prototype of AIDSVAX, Genentech gets the licensing fees. Also Genentech has all the options to produce the vaccine. VXGN does not have the capabilities for that.